Recent Finacing
Recent Raise
Theseus Pharmaceuticals, a Boston biotech developing pan-variant tyrosine kinase inhibitors, including THE-630 (pan-KIT for refractory GIST) and an EGFR C797S-resistant inhibitor, with an IND expected.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Theseus Pharmaceuticals.
